Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest accessnewswire.com · about 17 hours ago

BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline

VANCOUVER, BC / ACCESS Newswire / August 4, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to provide a comprehensive update on the progress of its proprietary sublingual thin-film drug delivery pipeline. The Company continues to advance multiple pharmaceutical development programs, including Cladribine for multiple sclerosis, autoimmune disease expansion, Everolimus and Semaglutide, while strengthening the intellectual property portfolio supporting its platform and preparing for the next phase of clinical and commercial development.

Press releases

More recent coverage

Page 43
URAIF prnewswire.com · about 17 hours ago

INTURAI VENTURES PROVES AIRBORNE PRESENCE INTELLIGENCE, ADDRESSING DEFENCE, SECURITY AND RESCUE MARKETS

(CSE: URAI  / OTC: URAIF / FSE: 3QG0) [email protected] Highlights Inturai's sensor, flown under a standard drone, mapped the locations of people and devices across an entire site, including inside buildings, in a single pass. Running on standard drones, the system is quick and affordable to deploy, with the commercial model focused on higher-margin software licences.

NXP globenewswire.com · about 17 hours ago

NXP Trimension Ultra-Wideband Powers BMW Group's Digital Key Plus and Presence Detection

NXP's Trimension Ultra-Wideband (UWB) ranging and radar solutions will be deployed by the BMW Group across its fleet, starting with selected 2026 vehicle programs NXP's Trimension NCJ29D6 family allows OEMs to use one UWB system for multiple use cases, from presence detection to hands-free car access NXP's single-chip secure UWB solution addresses both safety and convenience applications to maximize system value for OEMs Copyright © BMW AG EINDHOVEN, The Netherlands, Aug. 04, 2026 (GLOBE NEWSWIRE) -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that its Trimension NCJ29D6 family will be deployed in the BMW Group's fleet, starting with selected 2026 vehicle programs.

ACM newsfilecorp.com · about 17 hours ago

Allied Critical Metals Announces Update on the Second Tranche of Its U.S.$25 Million Equity Financing

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Allied Critical Metals Inc. (CSE: ACM) (OTCQB: ACMIF) (FSE: 0VJ0) ("Allied" or the "Company") is pleased to announce that further to the news release dated April 24, 2026, the Company is continuing to progress towards closing of the second tranche of the U.S.$25 million non-brokered private placement offering of common shares at a price of $2.05 per share (the "Offering") in the amount of U.S.$15 million second tranche (the "Second Tranche") with an existing strategic investor (the "Existing Strategic Investor") and a new strategic investor (the "New Strategic Investor", collectively the "Strategic Investors"). The Existing Strategic Investor has confirmed to the Company its intention to backstop the contemplated investment by the New Strategic Investor in the Second Tranche.

RHHBY businesswire.com · about 17 hours ago

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

PARIS--(BUSINESS WIRE)--Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche's investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-m.

ADTN businesswire.com · about 17 hours ago

TOHKnet and Adtran conduct Japan's first 50G PON trial on a live network

SENDAI, Japan--(BUSINESS WIRE)-- #5G--Adtran today announced that TOHKnet has completed Japan's first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran's SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existi.

PLD prnewswire.com · about 18 hours ago

Prologis Announces Recommended Acquisition of SEGRO plc

Combination expands Prologis' European platform  and enhances long-term growth opportunities SAN FRANCISCO, Aug. 4, 2026 /PRNewswire/ -- Prologis, Inc. (NYSE: PLD) today announced that it has reached agreement with the board of SEGRO plc (LSE: SGRO) on the terms of a recommended acquisition of SEGRO, valuing SEGRO's entire issued and to be issued ordinary share capital at approximately $18.8 billion. Daniel S. Letter, chief executive officer of Prologis, commented: "We are pleased to have reached agreement with the SEGRO Board on a combination that we believe will create meaningful value.

AUDC prnewswire.com · about 18 hours ago

AudioCodes Reports Second Quarter 2026 Results and Declares Semi-Annual Dividend of 20 cents per share

OR YEHUDA, Israel, Aug. 4, 2026 /PRNewswire/ --  Second Quarter Highlights Quarterly revenues increased by 3.1% year-over-year to $63 million; Quarterly services revenues increased by 6.2% year-over-year to $34.6 million; GAAP results:- Quarterly GAAP gross margin was 65.7%;- Quarterly GAAP operating margin was 5.1%;- Quarterly GAAP net income was $0.5 million, or $0.02 per diluted share. Non-GAAP results:- Quarterly Non-GAAP gross margin was 65.8%;- Quarterly Non-GAAP operating margin was 7.4%;- Quarterly Non-GAAP net income was $3.9 million, or $0.15 per diluted share; Net cash provided by operating activities was $6.1 million for the quarter.

PLC accessnewswire.com · about 18 hours ago

Great Western Mining Corporation PLC Announces Defender Tungsten Project Drilling Update

Addison Mining Services Engaged as Competent Person Ahead of Imminent Drilling DUBLIN, IRELAND / ACCESS Newswire / August 4, 2026 / Great Western Mining Corporation PLC (AIM:GWMO)(Euronext Growth:8GW)(OTCQB:GWMOF), a strategic minerals exploration and development company, is pleased to provide an update on the upcoming drilling programme at the Defender Tungsten Project ("Defender" or the "Project") in Mineral County, Nevada, USA. HIGHLIGHTS Drilling at Defender is expected to commence in the next two weeks, with all preparatory fieldwork now complete and drill pads constructed.

BETR businesswire.com · about 18 hours ago

CORRECTING and REPLACING Better Home & Finance Holding Company to Announce Second Quarter 2026 Results on August 6, 2026

NEW YORK--(BUSINESS WIRE)---- $BETR #BETR--Please replace the release dated July 29, 2026, with the following corrected version due to multiple revisions. The updated release reads:  BETTER HOME & FINANCE HOLDING COMPANY TO ANNOUNCE SECOND QUARTER 2026 RESULTS ON AUGUST 6, 2026 Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) (“Better” or the “Company”) today announced that the Company will issue its second quarter 2026 results after market close on Thursday, August 6, 2026. Leadership will.

IQM globenewswire.com · about 19 hours ago

IQM Quantum Computers Reports First Earnings as Public Company, Reporting First Half and Second Quarter 2026 Results, and Initiates FY 2026 Guidance Supported by Over EUR 102 million Order Backlog

IQM Quantum Computers Plc, Stock Exchange Release, Half year financial report August 4, 2026 at 08:00 (EEST) ESPOO, FINLAND | August 4, 2026 | IQM Quantum Computers Plc (Nasdaq: IQMX) (“IQM”, “IQM Quantum Computers” or the “Company”), a global leader in full-stack superconducting quantum computers, today announced its financial results for the first half and second quarter of 2026, ended on June 30, 2026. First Half and Year to Date 2026 Financial Highlights Order backlog of EUR 69.1 million as of June 30, 2026  EUR 33.0 million added to backlog since June 30, 2026, bringing total order backlog to over EUR 102.1 million as of August 3, 2026 Total revenues for the six months ended June 30, 2026, were EUR 8.9 million Operating loss for the six months ended June 30, 2026, was EUR 60.5 million Cash Balance of EUR 309.4 million as of July 2, 2026, inclusive of listing proceeds 2026 Financial Outlook:   Full-Year New Order Intake Target: EUR 65 million to EUR 75 million  Full-Year 2026 Revenue Target: EUR 42 million to EUR 47 million  First Half and Year to Date 2026 Operational Highlight s Expansion into several new markets, including Japan and Spain, through new customer wins and customer engagements 17 systems in total delivered globally to customers since founding, with 26 total systems sold Notably, first US delivery to US Department of Energy's Oak Ridge National Laboratory in Tennessee in June 2026 Strong new sales momentum with a landmark deal announced with CSC, where IQM was selected to integrate a quantum computer into the LUMI AI Factory, connected to one of the world's leading supercomputers Concrete use-cases exploration with Deutsche Bahn that demonstrated a hybrid quantum-classical railway scheduling solution using real operational data on today's IQM hardware Significant advancements in error correction, first introducing tile codes and further refining them with the "barbell codes"—a novel family of qLDPC error correction codes customized for the IQM Constellation topology, showing strong improvement in efficiency More than EUR 40 million investment into industrial expansion of our proprietary fab, doubling cleanroom capacity to enable the production of up to 30 full-stack quantum computers per year Key ecosystem partnerships and collaborations including with NVIDIA, conducting AI-driven parallel qubit calibration using the NVIDIA Ising open family of AI models, helping automate system tuning and improve system uptime Collaboration with HPE including integrating IQM's superconducting quantum computers with HPE Cray HPC infrastructure for hybrid enterprise environments Significantly strengthened and expanded board with independent industry professionals as board members Expanded management team with experienced key new hires, including CTO, COO and promoting Chief Scientist Hosted successful inaugural Capital Markets Day in June 2026.

WIX globenewswire.com · about 19 hours ago

Wix Reports Second Quarter 2026 Results

NEW YORK -- Wix.com Ltd. (Nasdaq: WIX) (the “Company”), today reported financial results for second quarter 2026. In addition, the Company provided its outlook for the third quarter and reiterated expectations for the full year 2026. Please visit the Wix Investor Relations website at https://investors.wix.com to view the Q2'26 Shareholder Update and other materials.

SNY globenewswire.com · about 19 hours ago

Press Release: Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease

Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Paris, August 4, 2026. Sanofi today announced that the European Commission (EC) has approved an extension of the indication for MenQuadfi (Meningococcal Group A, C, W and Y conjugate vaccine) to include infants from six weeks of age to help protect against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y.

NRIX globenewswire.com · about 19 hours ago

Nurix Therapeutics Announces First Patient Enrolled in Registrational Phase 3 DAYBreak CLL-306 Trial of Bexobrutideg in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Phase 3 trial designed to demonstrate superiority of bexobrutideg versus pirtobrutinib in patients with relapsed/refractory CLL/SLL previously treated with a covalent BTK inhibitor Phase 3 trial designed to demonstrate superiority of bexobrutideg versus pirtobrutinib in patients with relapsed/refractory CLL/SLL previously treated with a covalent BTK inhibitor

PWRL businesswire.com · about 20 hours ago

CORRECTING and REPLACING Powerlaw Corp. (Nasdaq: PWRL) Publishes Comprehensive Portfolio Intelligence Primer

SAN FRANCISCO--(BUSINESS WIRE)--Please replace the release dated July 23, 2026, with the following corrected version due to multiple revisions. The updated release reads: POWERLAW CORP. (NASDAQ: PWRL) PUBLISHES COMPREHENSIVE PORTFOLIO INTELLIGENCE PRIMER Powerlaw Corp. (Nasdaq: PWRL), a publicly traded closed-end fund advised by Powerlaw Fund Adviser, LLC, today announced that next week, it will release a Portfolio Intelligence Primer, offering in-depth insights into its investment portfolio th.

← Newer
Older →